
Acadia Healthcare has increased its 2026 adjusted EBITDA guidance and is pursuing network expansion despite facing operating and legal costs. While this indicates management's growing confidence in its expansion strategy, concerns persist regarding eroding earnings quality due to unresolved legal and regulatory investigations. The article suggests that while the guidance uplift is positive, the impact on durable profitability and the risks associated with legal costs remain central to the investment narrative.
Simply Wall Street
Original source

